To determine if a nonsurgical procedure is appropriate for your condition, we recommend scheduling a consultation with one of our licensed Regenexx network physicians. During this appointment, the doctor will assess your condition, discuss your eligibility for treatment, and answer any questions you may have about the procedure.

The ability to treat multiple body areas simultaneously depends on various factors. These include the physician's assessment, the amount of blood or bone marrow required for treatment, and the patient's comfort level. Each case is evaluated individually to determine if treating multiple areas in one session is feasible.

Laser therapy is a non-invasive medical treatment that uses specific light wavelengths to address painful and debilitating conditions. This approach aims to reduce discomfort and enhance function in affected body areas.

Regenexx injectate procedures are designed to treat common orthopedic conditions and help patients avoid surgery. A licensed Regenexx network physician uses image guidance to inject customized concentrations of the patient's own cells, derived from either blood or bone marrow, into the specific area(s) of injury.

While we can provide data on procedure results and assess your specific candidacy, it's important to note that no medical procedure can guarantee a complete restoration to pre-injury condition. Like all medical interventions, Regenexx injectate procedures have both success and failure rates. You can review patient-reported data on pain reduction and joint function improvement for up to six years post-procedure in our Patient Results section.

According to U.S. Department of Health and Human Services guidelines for complication reporting, any complications associated with Regenexx injectate procedures have been categorized as mild to moderate and are rare. We have published a comprehensive safety study on bone marrow concentrate, which contains adult stem cells. This study showed no serious procedure-related complications and no instances of patients developing cancer related to bone marrow concentrate use. You can review our Safety Paper for more detailed information.

Regenexx procedures are designed with patient comfort in mind. Regenexx SCP and PL injectate procedures begin with a standard blood draw. The Regenexx SD injectate procedure requires a bone marrow aspirate under local anesthesia, which is significantly less invasive than a bone marrow biopsy. Local anesthesia is used to numb the treatment area(s). Post-procedure, patients may experience some soreness in the joint and injection site(s). Your physician will provide guidance on pain management and activity limitations following the procedure.

Typically, patients can return to normal daily activities as tolerated. Most individuals resume light activities after 5 to 7 days and return to sports after 6 to 8 weeks. Improvement may continue over several months. Your physician will provide personalized guidance on post-procedure activities based on your specific condition and the recommended treatment.

Regenexx SCP (Super Concentrated Platelets) injectate is a blood-based procedure, utilizing a highly concentrated form of platelet-rich plasma (PRP). In contrast, Regenexx SD (Same Day) injectate is a bone marrow concentrate (BMC) based procedure that contains the patient's own stem cells. The SD procedure involves harvesting, concentrating, and reinjecting the cells on the same day.

Regenexx distinguishes its SD injectate procedure from generic "stem cell procedures." The term "stem cell therapy" has been appropriated by companies selling products derived from birth tissues, often labeled as containing stem cells. In contrast, the Regenexx SD injectate procedure uses bone marrow concentrate containing the patient's own stem cells. This approach provides customized concentrations of the patient's cells, tailored to their specific condition or injury needs.